These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
516 related items for PubMed ID: 7859237
21. Pharmacology of the bipyridines: amrinone and milrinone. Alousi AA, Johnson DC. Circulation; 1986 Mar; 73(3 Pt 2):III10-24. PubMed ID: 2417744 [Abstract] [Full Text] [Related]
22. [The hemodynamic effects of the combination of milrinone in heart failure refractory to treatment with dopamine, dobutamine and/or nitroprusside]. Domínguez de Rozas JM, Guindo Soldevila J, Rodríguez Font E, Martínez Vílchez R. Rev Esp Cardiol; 1994 Oct; 47(10):682-6. PubMed ID: 7991922 [Abstract] [Full Text] [Related]
23. Role of force--frequency relation during AV-block, sinus node block and beta-adrenoceptor block in conscious animals. De Pauw M, Vilaine JP, Heyndrickx GR. Basic Res Cardiol; 2004 Sep; 99(5):360-71. PubMed ID: 15338245 [Abstract] [Full Text] [Related]
24. [Efficacy of intravenous milrinone in the treatment of acute congestive cardiac failure. Results of a French multicenter study]. Dubois-Randé JL, Guérot C, Jan F, Brochier M, Sacrez A, Vacheron A, Bory M, Lambert H, Pony JC, Le Bloc'h Y. Ann Cardiol Angeiol (Paris); 1993 Feb; 42(2):105-14. PubMed ID: 8494318 [Abstract] [Full Text] [Related]
25. [Value of the use of milrinone in the treatment of acute crisis in patients with congestive heart failure]. Gun C, Piegas LS, Bianco AC, Freire RB, Ramos RF, Timerman A. Arq Bras Cardiol; 1995 Sep; 65(3):255-8. PubMed ID: 8579514 [Abstract] [Full Text] [Related]
26. Comparisons of the depressor, inotropic and renal effects of milrinone and CI-930 to different pure vasodilators and diuretics in conscious instrumented dogs. Lee KC, Clas DM, Gorczyca WP, Silver PJ, Ezrin AM. Drugs Exp Clin Res; 1991 Sep; 17(7):323-36. PubMed ID: 1686584 [Abstract] [Full Text] [Related]
27. Cardiovascular effects of the novel Ca2+-sensitiser EMD 57033 in pigs at rest and during treadmill exercise. Stubenitsky R, van der Weerd RW, Haitsma DB, Verdouw PD, Duncker DJ. Br J Pharmacol; 1997 Dec; 122(7):1257-70. PubMed ID: 9421271 [Abstract] [Full Text] [Related]
28. Aortic peak flow velocity as an index of myocardial contractility in the conscious rat. Dowell RT, Houdi AA. Methods Find Exp Clin Pharmacol; 1997 Oct; 19(8):533-9. PubMed ID: 9442476 [Abstract] [Full Text] [Related]
29. Milrinone, dobutamine, and nitroprusside: comparative effects on hemodynamics and myocardial energetics in patients with severe congestive heart failure. Monrad ES, Baim DS, Smith HS, Lanoue AS. Circulation; 1986 Mar; 73(3 Pt 2):III168-74. PubMed ID: 3510773 [Abstract] [Full Text] [Related]
30. A randomized multicenter study comparing the efficacy and safety of intravenous milrinone and intravenous nitroglycerin in patients with advanced heart failure. Loh E, Elkayam U, Cody R, Bristow M, Jaski B, Colucci WS. J Card Fail; 2001 Jun; 7(2):114-21. PubMed ID: 11420762 [Abstract] [Full Text] [Related]
31. Assessment of long-term therapy with milrinone and the effects of milrinone withdrawal. Monrad ES, Baim DS, Smith HS, Lanoue AS, Silverman KJ, Gervino EV, Grossman W. Circulation; 1986 Mar; 73(3 Pt 2):III205-12. PubMed ID: 3510776 [Abstract] [Full Text] [Related]
32. Hemodynamic response and effects on myocardial energetics of 3-cyano-2-morpholino-5-(pyrid-4-yl)pyridine (AWD 122-14) in anesthetized minipigs. Rohde E, Wiesner B, Muschick P. Pharmazie; 1993 Sep; 48(9):690-4. PubMed ID: 8234405 [Abstract] [Full Text] [Related]
34. Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 2nd communication: studies in dogs. Ohhara H, Ogawa T, Takeda M, Katoh H, Daiku Y, Igarashi T. Arzneimittelforschung; 1989 Jan; 39(1):38-45. PubMed ID: 2719742 [Abstract] [Full Text] [Related]
35. Calcitonin gene-related peptide in vivo positive inotropy is attributable to regional sympatho-stimulation and is blunted in congestive heart failure. Katori T, Hoover DB, Ardell JL, Helm RH, Belardi DF, Tocchetti CG, Forfia PR, Kass DA, Paolocci N. Circ Res; 2005 Feb 04; 96(2):234-43. PubMed ID: 15591228 [Abstract] [Full Text] [Related]
36. Phosphodiesterase III inhibition or adrenoreceptor stimulation: milrinone as an alternative to dobutamine in the treatment of severe heart failure. Mager G, Klocke RK, Kux A, Höpp HW, Hilger HH. Am Heart J; 1991 Jun 04; 121(6 Pt 2):1974-83. PubMed ID: 1852090 [Abstract] [Full Text] [Related]
38. Effect of milrinone on ethanol and halothane induced cardiodepression. Neira S, Penna M. Acta Physiol Pharmacol Latinoam; 1988 Jun 04; 38(2):193-211. PubMed ID: 2847492 [Abstract] [Full Text] [Related]
39. Myocardial actions of milrinone: characterization of its mechanism of action. Rapundalo ST, Grupp I, Grupp G, Abdul Matlib M, Solaro RJ, Schwartz A. Circulation; 1986 Mar 04; 73(3 Pt 2):III134-44. PubMed ID: 2417746 [Abstract] [Full Text] [Related]
40. [Hemodynamic effects of various doses of a new inotropic: amrinoma]. Cárdenas M, Vidaurri A. Arch Inst Cardiol Mex; 1979 Mar 04; 49(5):961-8. PubMed ID: 122781 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]